Idenix's (IDIX) Renaud Says Will Take 18-24 Months to Resolve Patent Case with Gilead (GILD) -Reuters

Article Stock Quotes (2) Comments (0)

Traders should watch Idenix Pharma (Nasdaq: IDIX) shares as Reuters is reporting the company's CEO Ron Renaud has said he believes it will take about 18-24 months in order to resolve the patent cases with Gilead (Nasdaq: GILD).

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Intuitive Surgical (ISRG) Jury Reaches Positive Verdict in Robot Case; Shares Rise
• Saks (SKS) Won't Comment on Tonight's Takeover 'Rumor'
• KKR & Co. Might Push for Neiman Marcus, Saks (SKS) Merger

Create E-mail Alert Related Categories

Litigation, Rumors

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?